You are in : Home » Results & submissions » Select UOA » 1 - Clinical Medicine » View submission: University of Cambridge » Outputs » Detail

Output details

1 - Clinical Medicine

Output 28 of 750 in the submission

Article title

A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors.

Type

D - Journal article

DOI

Title of journal

Clin Cancer Res

Article number

Volume number

Issue number

First page of article

1561

ISSN of journal

1078-0432

Year of publication

2011

URL

Number of additional authors

Additional information

Interdisciplinary

Cross-referral requested

Research group

None

Citation count

Proposed double-weighted

Double-weighted statement

Reserve for a double-weighted output

Non-English

English abstract